NASDAQ:ANTX | Profit Breakdown | AN2 Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$8.9M-$8.19M
2026-03-31-$10.55M-$10.03M
2025-12-31-$9.32M-$8.67M
2025-09-30-$10.04M-$9.35M
2025-06-30-$7.22M-$6.46M
2025-03-31-$11.54M-$10.65M
2024-12-31-$8.6M-$7.52M
2024-09-30-$14.01M-$12.75M
2024-06-30-$15.88M-$14.44M
2024-03-31-$18.3M-$16.62M
2023-12-31-$18.82M-$16.93M
2023-09-30-$18.18M-$16.71M
2023-06-30-$16.6M-$15.8M
2023-03-31-$16.04M-$15.32M
2022-12-31-$12.48M-$11.84M
2022-09-30-$11.77M-$11.34M
2022-06-30-$10.33M-$10.12M
2022-03-31-$7.68M-$7.66M
2021-12-31-$7.59M-$7.55M
2021-09-30-$6.93M-$6.94M
2021-06-30-$5M-$5.01M
2021-03-31-$2.05M-$2.05M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$38.11M-$35.17M
2024-12-31-$56.79M-$51.32M
2023-12-31-$69.64M-$64.73M
2022-12-31-$42.26M-$40.96M
2021-12-31-$21.57M-$21.54M